69 related articles for article (PubMed ID: 21774727)
1. NFKBIA deletion in glioblastomas.
Idbaih A; Marie Y; Sanson M
N Engl J Med; 2011 Jul; 365(3):277; author reply 277-8. PubMed ID: 21774727
[No Abstract] [Full Text] [Related]
2. NFKBIA deletion in glioblastomas.
Bredel M; Scholtens DM; Yadav AK; Alvarez AA; Renfrow JJ; Chandler JP; Yu IL; Carro MS; Dai F; Tagge MJ; Ferrarese R; Bredel C; Phillips HS; Lukac PJ; Robe PA; Weyerbrock A; Vogel H; Dubner S; Mobley B; He X; Scheck AC; Sikic BI; Aldape KD; Chakravarti A; Harsh GR
N Engl J Med; 2011 Feb; 364(7):627-37. PubMed ID: 21175304
[TBL] [Abstract][Full Text] [Related]
3. Alteration in NFKBIA and EGFR in glioblastoma multiforme.
Komotar RJ; Starke RM; Connolly ES; Sisti MB
Neurosurgery; 2011 Jun; 68(6):N14-5. PubMed ID: 21778941
[No Abstract] [Full Text] [Related]
4. NFKBIA deletion in glioblastomas.
Takeuchi S; Nawashiro H
N Engl J Med; 2011 Jul; 365(3):276-7; author reply 277-8. PubMed ID: 21774728
[No Abstract] [Full Text] [Related]
5. Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.
Patanè M; Porrati P; Bottega E; Morosini S; Cantini G; Girgenti V; Rizzo A; Eoli M; Pollo B; Sciacca FL; Pellegatta S; Finocchiaro G
Mol Cancer; 2013 Dec; 12():160. PubMed ID: 24330732
[TBL] [Abstract][Full Text] [Related]
6. Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.
Zhao Z; Zhong X; Wu T; Yang T; Chen G; Xie X; Wei Y; Ye M; Zhou Y; Du Z
Int J Mol Med; 2014 Nov; 34(5):1233-40. PubMed ID: 25215581
[TBL] [Abstract][Full Text] [Related]
7. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.
Mellinghoff IK; Wang MY; Vivanco I; Haas-Kogan DA; Zhu S; Dia EQ; Lu KV; Yoshimoto K; Huang JH; Chute DJ; Riggs BL; Horvath S; Liau LM; Cavenee WK; Rao PN; Beroukhim R; Peck TC; Lee JC; Sellers WR; Stokoe D; Prados M; Cloughesy TF; Sawyers CL; Mischel PS
N Engl J Med; 2005 Nov; 353(19):2012-24. PubMed ID: 16282176
[TBL] [Abstract][Full Text] [Related]
9. EGFR gene amplification in glioblastomas. Is there a relationship with morphology of tumor cell nuclei and proliferative activity?
Nafe R; Glienke W; Schlote W; Schneider B
Anal Quant Cytol Histol; 2001 Apr; 23(2):135-43. PubMed ID: 11332080
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
Miyanaga T; Hirato J; Nakazato Y
Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.
Thomas CY; Chouinard M; Cox M; Parsons S; Stallings-Mann M; Garcia R; Jove R; Wharen R
Int J Cancer; 2003 Mar; 104(1):19-27. PubMed ID: 12532415
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of EGFR in colorectal cancers and glioblastomas.
Barber TD; Vogelstein B; Kinzler KW; Velculescu VE
N Engl J Med; 2004 Dec; 351(27):2883. PubMed ID: 15625347
[No Abstract] [Full Text] [Related]
14. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.
von Deimling A; Louis DN; von Ammon K; Petersen I; Hoell T; Chung RY; Martuza RL; Schoenfeld DA; Yaşargil MG; Wiestler OD
J Neurosurg; 1992 Aug; 77(2):295-301. PubMed ID: 1320666
[TBL] [Abstract][Full Text] [Related]
15. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
[TBL] [Abstract][Full Text] [Related]
16. PAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation.
Fiano V; Ghimenti C; Imarisio S; Silengo L; Schiffer D
Anticancer Res; 2004; 24(5A):2643-7. PubMed ID: 15517868
[TBL] [Abstract][Full Text] [Related]
17. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
Okada Y; Hurwitz EE; Esposito JM; Brower MA; Nutt CL; Louis DN
Cancer Res; 2003 Jan; 63(2):413-6. PubMed ID: 12543796
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of molecular markers in a series of 220 primary glioblastomas.
Houillier C; Lejeune J; Benouaich-Amiel A; Laigle-Donadey F; Criniere E; Mokhtari K; Thillet J; Delattre JY; Hoang-Xuan K; Sanson M
Cancer; 2006 May; 106(10):2218-23. PubMed ID: 16568472
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in NFKBIA gene is associated with recurrent acute rejections in liver transplant recipients.
Kramer K; Thye T; Treszl A; Peine S; Koch M; Sterneck M; Nashan B; Thude H
Tissue Antigens; 2014 Oct; 84(4):370-7. PubMed ID: 25112903
[TBL] [Abstract][Full Text] [Related]
20. HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients.
Katarina K; Daniela P; Peter N; Marianna R; Pavlina C; Stepanka P; Jan L; Ludmila T; Michal A; Marie C
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):124-9. PubMed ID: 17318773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
